Alcura France has accepted an irrevocable offer from Santé Cie Group to sell its home healthcare operations, facilitating a strategic focus on core service areas.

Information on the Target

Alcura France, a wholly owned subsidiary of Mutares SE & Co. KGaA, has received an irrevocable offer to divest its Care Services division, specifically focusing on home healthcare known as PSAD (Prestations de Santé à Domicile). This division generated approximately EUR 17 million in revenue in France during 2024. The acquisition is poised to enhance the efficiency and focus of Alcura France by divesting non-core operations while allowing the company to concentrate on its primary care services.

The buyer, Santé Cie Group, is recognized as a leading European provider of home and outpatient care services. This acquisition reflects the strategic importance of home healthcare, which has seen an increasing demand due to demographic changes and a growing preference for at-home care solutions.

Industry Overview in France

The home healthcare industry in France is undergoing significant transformation, driven by an aging population and advancements in medical technology. With an increasing number of individuals opting for home care services as a

View Source

Similar Deals

Warburg Pincus Sebia

2026

Other Private Equity Bio Diagnostics & Testing France
GENEO Capital Entrepreneur Seiven

2025

Other Private Equity Healthcare Facilities & Services (NEC) France
Santé Cie Group Locapharm

2025

Other Private Equity Home Healthcare Services France
Vesper Next Generation Infrastructure Fund I SCSp and Infracapital SAF Aerogroup

2025

Other Private Equity Ambulance & Emergency Services France
IMDEV centre d'Imagerie Médicale Saint-Claude

2024

Other Private Equity Hospitals, Clinics & Primary Care Services France

Santé Cie Group

invested in

Alcura France

in 2025

in a Other Private Equity deal

Disclosed details

Revenue: $19M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert